Cargando…
Differential regulation of wild-type and mutant alpha-synuclein binding to synaptic membranes by cytosolic factors
BACKGROUND: Alpha-Synuclein (α-syn), a 140 amino acid protein associated with presynaptic membranes in brain, is a major constituent of Lewy bodies in Parkinson's disease (PD). Three missense mutations (A30P, A53T and E46K) in the α-syn gene are associated with rare autosomal dominant forms of...
Autores principales: | Wislet-Gendebien, Sabine, Visanji, Naomi P, Whitehead, Shawn N, Marsilio, Diana, Hou, Weimin, Figeys, Daniel, Fraser, Paul E, Bennett, Steffany AL, Tandon, Anurag |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2562387/ https://www.ncbi.nlm.nih.gov/pubmed/18808659 http://dx.doi.org/10.1186/1471-2202-9-92 |
Ejemplares similares
-
Retraction Note to: Differential regulation of wild-type and mutant alpha-synuclein binding to synaptic membranes by cytosolic factors
por: Wislet-Gendebien, Sabine, et al.
Publicado: (2021) -
Alpha-Synuclein Targeting Therapeutics for Parkinson's Disease and Related Synucleinopathies
por: Menon, Sindhu, et al.
Publicado: (2022) -
Beyond the synucleinopathies: alpha synuclein as a driving force in neurodegenerative comorbidities
por: Visanji, Naomi P., et al.
Publicado: (2019) -
Using neurolipidomics to identify phospholipid mediators of synaptic (dys)function in Alzheimer's Disease
por: Bennett, Steffany A. L., et al.
Publicado: (2013) -
Adult Bone Marrow: Which Stem Cells for Cellular Therapy Protocols in Neurodegenerative Disorders?
por: Wislet-Gendebien, Sabine, et al.
Publicado: (2012)